Save for a few minutes at the start, the Switzerland market languished in negative territory on Tuesday, due largely to heavy selling at the drugmaker Novartis counter.
The benchmark SMI ended with a loss of 221.77 points or 1.55% at 14,057.61. The index, which edged up to 14,342.71 at the open, dropped to a low of 14,035.88 in the session.
Novartis tanked nearly 11%. The counter clocked a volume of over 10.4 million shares today. The stock tumbled after the company said that its experimental drug for a muscle-wasting disorder failed a late-stage study, the second major trial setback in days.
Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial – No Payment Required
Swiss Stocks Slide On Novartis Experimental Drug Setback
2026-09-08 17:50:47
